CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beijing SL Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beijing SL Pharmaceutical Co Ltd
No. 69 Fushi Road, Haidian District
Phone: +86 1088627635p:+86 1088627635 BEIJING, BEJ  100143  China Ticker: 002038002038
Business Summary
Beijing SL Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of genetic engineering and related drugs. The Company's main products include complex coenzyme, arsenic trioxide, recombinant human granulocyte stimulating factor, recombinant human interleukin-2, recombinant human basic fibroblast growth factor, thymopentin, enoxaparin and Xingling dropping pills, among others. The Company distributes its products in domestic market and to overseas markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager MingboXu 60 3/7/2004 3/7/2004
Finance Director LiJi 43 4/24/2023 4/24/2023
Secretary of the Board, Director ShujieLiang 58 4/24/2009 6/1/2003
4 additional Officers and Directors records available in full report.

Business Names
Business Name
002038
Beijing SL Pharmaceutical Co., Ltd.

General Information
Number of Employees: 856 (As of 12/31/2023)
Outstanding Shares: 1,027,350,000 (As of 9/30/2024)
Shareholders: 75,531
Stock Exchange: SHE
Fax Number: +86 1088795883


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024